A carregar...
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer
BACKGROUND: Bevacizumab treatment is subject to large interpatient variability in efficacy, which may partly be explained by differences in complex bevacizumab pharmacokinetic characteristics that influence bevacizumab exposure. Exposure–response relationships have been identified for other monoclon...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543296/ https://ncbi.nlm.nih.gov/pubmed/32272489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0835 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|